Evidence map›Paper›PMID 18541147›Full record

ArticleBiochemical and biophysical research communications2008

hnRNP G elicits tumor-suppressive activity in part by upregulating the expression of Txnip.

Ki-Hyuk Shin, Reuben H Kim, Roy H Kim, Mo K Kang, No-Hee Park

Open access · greenAbstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Potential mechanism of inhibitory effect of "medicine food homology" curcumin and its analogue EF24 on oral squamous cell carcinoma.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ki-Hyuk ShinSchool of Dentistry, University of California, CHS 43-033, 10833 Le Conte Avenue, Los Angeles, CA 90095, USA. kshin@dentistry.ucla.edu
Reuben H Kim
Roy H Kim
Mo K Kang
No-Hee Park
University of California, Los Angeles · USUCLA Jonsson Comprehensive Cancer Center

Funding

HPV, Genetic Instability &Oral CancerR01DE014147 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PARK, NO-HEE · 2001 to 2005
$1.2M
DNA Repair and p53 in Oral CancerR03DE015902 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SHIN, KI-HYUK · 2004 to 2005
$154k
NIDCR NIH HHS DE14147NIDCR NIH HHS DE15902NIDCR NIH HHS R01 DE014147NIDCR NIH HHS R03 DE015902
6 · The paper itself

Abstract

Heterogeneous nuclear ribonuclearproteins (hnRNPs) are nucleic acid-binding proteins and have critical roles in DNA repair, telomere regulation, and transcriptional gene regulation. Previously, we showed that hnRNP G has tumor-suppressive activity in human oral squamous cell carcinoma cells. Therefore, the identification of hnRNP G target genes is important for understanding the function of hnRNP G and its tumor-suppressive activity. In this study, we identify a known tumor suppressor gene, thioredoxin-interacting protein (Txnip) gene as a novel target of hnRNP G. Expression of Txnip is upregulated by wild-type (wt) hnRNP G but not by a suppression-defective mutant hnRNP G (K22R) in human squamous cell carcinoma. Wt hnRNP G binds and transactivates the Txnip promoter in vivo, whereas the K22R mutant does not. Furthermore, overexpression of Txnip alone in cancer cells leads to the inhibition of anchorage-independent growth and in vivo tumorigenicity in immunocompromised mice, suggesting a reversion of the transformation phenotype. These studies indicate that hnRNP G promotes the expression of Txnip and mediates its tumor-suppressive effect.

Indexed as

Gene Expression Regulation, NeoplasticTranscriptional ActivationCarrier ProteinsCell Line, TumorCell ProliferationHeterogeneous-Nuclear RibonucleoproteinsHumansPromoter Regions, GeneticTumor Suppressor ProteinsUp-RegulationCarrier ProteinsHeterogeneous-Nuclear RibonucleoproteinsRBMX protein, humanTumor Suppressor ProteinsTXNIP protein, human

Identifiers

PMID18541147
PMCPMC2519094
OpenAlexW1966807221

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.